DENVER, Colo.--(BUSINESS WIRE)--ELA Medical, Inc., a Sorin Group (MIL:SRN) company, announced the first U.S. enrollment in the OPTION study (Optimal Anti-tachycardia Therapy in ICD Patients without Pacing Indications) by Dan Dan, M.D., Electrophysiologist and Co-Director of Cardiovascular Research of the Fuqua Heart Center at Piedmont Hospital, Atlanta, GA.
